2013 Apr 15 Annual Report 2012 - Phosphagenics
2013 Apr 15 Annual Report 2012 - Phosphagenics
2013 Apr 15 Annual Report 2012 - Phosphagenics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Directors’ <strong>Report</strong> continued<br />
REMUNERATION REPORT (AUDITED) (CONTINUED)<br />
The Group’s current remuneration policies provide a signifi cant degree of linkage between an executive’s<br />
variable long term incentive remuneration and the overall fi nancial performance of the Group. Given the<br />
position of the Group and its stage of development, the remuneration is aimed at retaining key individuals<br />
to ensure the success of current and future product development and successful commercialisation<br />
of products, which will in turn impact future profi tability of the Group and shareholder wealth.<br />
Employment contracts<br />
No executives have fi xed term contracts with the Group. The company or the executive may terminate<br />
employment by providing four weeks written notice. On termination, any long term incentive plan<br />
(ESOP) options or (ECRS) rights that have vested are available to be exercised. Any options or rights<br />
that have not yet vested will be forfeited.<br />
The company may terminate employment at any time without notice if serious misconduct has<br />
occurred. Where termination with cause occurs the executive is only entitled to that portion<br />
of remuneration that is fi xed, and only up to the date of termination. On termination with cause,<br />
any unvested options or rights will immediately be forfeited.<br />
Company performance and its link to long-term incentives<br />
The fi nancial performance measures driving long-term incentive vesting and payment outcomes are<br />
revenues from the sale of goods and Company share price. Because of the stage of the Company’s<br />
development, earnings per share and other profi tability based measures do not accurately refl ect<br />
performance over the past fi ve years.<br />
The following chart shows <strong>Phosphagenics</strong> Limited’s annual revenues from the sale of goods and year<br />
end share price over the fi ve-year period from 1 January 2008 to 31 December <strong>2012</strong>.<br />
39<br />
3.0<br />
Company Performance 2008 to <strong>2012</strong><br />
2.5<br />
2.0<br />
1.5<br />
1.0<br />
0.5<br />
0.0<br />
2008<br />
2009<br />
2010<br />
2011<br />
<strong>2012</strong><br />
Revenue from sale of goods<br />
31 December Share Price<br />
Options granted during the year to key management personnel<br />
No options were awarded during the year to key management personnel and no options vested during the year.<br />
Performance Rights granted during the year to key management personnel<br />
1,450,000 ECRS Rights were awarded to key management personnel during the year, of which nil vested.<br />
Remuneration of key management personnel<br />
Aggregates <strong>2012</strong><br />
$<br />
2011<br />
$<br />
Short-Term Benefi ts 1,645,236 1,568,076<br />
Post-Employment 135,780 1<strong>15</strong>,125<br />
Share Based Payment 238,440 95,119<br />
Termination <strong>15</strong>,508 275,742<br />
Totals 2,034,964 2,054,062<br />
DIRECTOR’S REPORT